This content is machine translated Journal Club Atopic dermatitis and the skin microbiome: new study findings Exploring the links between the cutaneous microbiome and the severity of atopic dermatitis (AD) and patient-related co-factors is an important aspect in the development of new personalized AD therapies, especially…
View Post 3 min This content is machine translated Plaque psoriasis New “Real World” Study on Tildrakizumab In a retrospective study of 30 patients with moderate to severe plaque psoriasis, the use of the IL-23 inhibitor tildrakizumab was shown to be effective and safe in clinical practice.…
